Skip to main content
Premium Trial:

Request an Annual Quote

People in the News: Clay Siegall


Mirna Therapeutics has appointed Clay Siegall as an outside director on its board.

Siegall is the co-founder, president, and CEO of Seattle Genetics. He previously held various positions with Bristol-Myers Squibb and the National Cancer Institute.

The Scan

For Better Odds

Bloomberg reports that a child has been born following polygenic risk score screening as an embryo.

Booster Decision Expected

The New York Times reports the US Food and Drug Administration is expected to authorize a booster dose of the Pfizer-BioNTech SARS-CoV-2 vaccine this week for individuals over 65 or at high risk.

Snipping HIV Out

The Philadelphia Inquirer reports Temple University researchers are to test a gene-editing approach for treating HIV.

PLOS Papers on Cancer Risk Scores, Typhoid Fever in Colombia, Streptococcus Protection

In PLOS this week: application of cancer polygenic risk scores across ancestries, genetic diversity of typhoid fever-causing Salmonella, and more.